Pharmaclinics are different from Mediclinics

Pharmaclinics are different from Mediclinics

Monopoly-is this the motto behind delayed subject addition issue?

Who are the stakeholders for pharmD(PB)? Who will protect our rights ?who will see our benefits are taken care of instead of thinking about others/PharmD , let us think about ourselves /PharmD(PB).Once you are happy then only you are able to keep others happy isnt it?one official association should be made there concerning the benefits of PharmD(PB) and for the protection of rights of pharmd(PB) students, who will take care of any issues related with PharmD(PB).whats ur say?Any talk related with the betterment of pharmD(PB) students should be encouraged here.Friends,my opinions are entirely my own and I can recommend them. I agree with you on some of the points u made here on this post, but my issue is that there should be some uniformity through out the country regarding the syllabus of a PharmD/PharmD(PB) curriculum.thats all i have to say.When I paid an amount as fees in my college to get some degree and study a curriculum, i just want to make it sure that i get the best out of it. My concern is only that the fundamental, basic ,core subjects like pathophysiology, hospital Pharmacy and community pharmacy must get added in the PharmD(PB) syllabus,this year before i pass out. I am not blaming entirely to organizations like PCI and universities for this.When I took admission in PharmD(PB), I was ignorant about this syllabus issue, but now today when i came to know about this, i want to rectify it and make other pharmD(PB) students like me ,aware about the same. However I guess some blame also goes to the abovesaid parent organizations, as when they are launching and approving a course, they should ensure that all is well, because i expect an organization's vision should be much broader than an individual's.It seems as if the Pharm- D (PB) syllabus has been structured by some beheaded ghost. However as they say you are responsible for your own life. I am not against PharmD regular, I wish them all the best and all the luck. But I am worried about myself and PharmD(PB) syllabus . There is nothing wrong in it!!!Now a days when it snows or rains, 5% of people go outside and play and enjoy it ; while 95% make a Facebook status about it.
Purpose is get aware and do something about the issue, just dont sit there doing nothing.
On pharmaceutical events and on Facebook also I see students worrried and talking about trival issues like putting prefix " Dr" infront of their name in internship or after getting degree.
all tactics to mislead students from real issue. It doesnt matter whether they write PharmD or doctor of pharmacy in degree, ultimately you remain a pharmacist.
My opinion:The real issue is they dont want to add the mentioned subjects in other universities except in deemed universities like JSS and Manipal, who dont depend on others to add any subjects in their syllabus. Thats why their fees is exceptionally high in comparison to other universities and colleges . For pharmD(PB) 3 yrs course ,they ask 9 lakhs as fees. And Dr B.Suresh who is South Indian himself, had his whole schooling, gradution and postgraduation in Mysore,South India, is also Principal of the JSS college as well as Chairman of JSS univ,who also happens to be the PCI president.They want to create monopoly and enjoy the exclusive status of colleges/universities with advantages of having additional subjects. The more delay it gets for years,the more these exclusive universities enjoy this benefit.Quote:You can tell monopoly is an old game because there is a luxary tax and super rich people can go to jail.Quote : Power corrupts, absolute power absolutely.

Or 

Office and functionaries are not matching in performance with Dr B Suresh's vision and dynamism. 

Now PharmD(PB) course is unavailable in Indian Government Colleges. While Pharm. D was approved for the 2022-2023 academic session with 30 admissions, the closure of the PB program was finalized for the following year.

Pharm.D (Post Baccalaureate) was unavailable in India's government colleges as of the 2021-2022 academic year. This decision was made to close the Pharm. D (PB) program starting from the 2021-2022 session, subject to the examining authority submitting a disaffiliation letter. While Pharm. D was approved for the 2022-2023 academic session with 30 admissions, the closure of the PB program was finalized for the following year. 

The main reason why Pharm. D (Post Baccalaureate) courses are often unavailable in government colleges is due to regulations and funding constraints, particularly regarding the need for extensive hospital infrastructure and faculty. Privately run colleges are often better positioned to meet these requirements due to potentially higher funding and flexibility in resource allocation.

Will Pharm-D course bringup such Pharmacovigilance Centers and Pharmaclinic Setups where FDI will be huge ?

Will Pharm-D course bringup such Pharmacovigilance Centers and Pharmaclinic Setups where FDI ( Foreign Direct Investment) will be huge ? 

Really ??? ... Not Confirmed...!!! 

#PharmacyAct1948- Replace

##PharmacyAct1948- Replace

The Pharmacy Act, 1948,  has not evolved in tandem with the dynamic growth of healthcare in India. Its structural and functional inadequacies have led to serious consequences in producing professionally sound pharmacy councils, quality educational institutions, and competent pharmacists capable of earning parity and respect alongside co-professionals.

1. Outdated Obsolete Act:

The Act lacks provisions that reflect the current needs of the pharmacy profession. It does not address modern clinical roles, inter-professional collaboration, digital health integration, or pharmaceutical care responsibilities that are now vital for pharmacists globally. The absence of contemporary revisions has rendered the Act obsolete in nurturing modern pharmacy practice.

2. Weak Regulation sans Authority:

The Act provides limited authority and accountability mechanisms for the Pharmacy Council of India and State Councils, as they lack vision, functional autonomy, and performance standards, resulting in inconsistent regulation of pharmacy education and practice. Council elections are often politicized rather than merit-driven, leading to compromised leadership.

3. Deficient Educational Standards:

The Act’s provisions for approving institutions and courses have not kept pace with advancements in pharmacy science. There is no robust mechanism to ensure teaching quality, infrastructure adequacy, or continuous curriculum revision. As a result, many institutions focus on quantity over quality, producing graduates with inadequate clinical skills and limited inter-professional exposure.

4. No mandate on Continuing Professional Development (CPD):

The Act does not mandate or promote structured CPD or re-licensing causing professional stagnation, with many pharmacists failing to upgrade their knowledge or adapt to changing healthcare paradigms.

5. Limited Scope for Practice. There is no body to, Regulate and issue license for Clinical Practice.

The Act fails to recognize or  to facilitate expanded pharmacy roles such as clinical pharmacy, Specialized therapy management,  emergency response preparedness etc.This restricts pharmacists and limits their recognition by other healthcare professionals.

6. Poor Integration with National Health Policy:

Pharmacy as a profession remains sidelined in policy discourse due to the Act’s failure to align pharmacy practice with national health goals. Pharmacists are underutilized in public health programs, disease prevention, and primary healthcare delivery.

To restore professional credibility and produce pharmacists who are clinically competent, ethically grounded, and respected by co-professionals, the Pharmacy Act requires comprehensive overhaul. It must be modernized to enforce strict educational standards, support CPD, empower councils, and formally recognize pharmacists as vital healthcare providers. Without these reforms, the Act remains a missed opportunity in strengthening India’s healthcare workforce.

#MoHFw, #PMOIndia, #PCI

Pov: Bhagwan P. S

#BlunderHasHappened - Time to wakeup

#BlunderHasHappened - Time to wakeup 

The Pharmacy Council of India (PCI), as the statutory body governing pharmacy education and practice in India, introduced the Pharm.D program in 2008 with the vision of integrating pharmacists into clinical settings as vital members of the healthcare team. However, despite its ambitious goals, the PCI bears partial responsibility for the lack of opportunities faced by Pharm.D graduates today.

Where PCI went wrong:

1. Inadequate Stakeholder Engagement:

The program was introduced without a strong framework involving collaboration with major healthcare stakeholders such as the Medical Council of India (now NMC), hospitals, healthcare policy makers, and employers. This resulted in a lack of formal recognition of Pharm.D professionals in clinical roles within hospitals.

2. Poor Integration with Healthcare System:

PCI failed to ensure the creation of structured job roles for Pharm.D graduates in both public and private healthcare systems. Unlike MBBS or BDS programs, there was no mandate or roadmap to integrate Pharm.Ds into government hospitals or primary health centers.

3. Insufficient Policy Advocacy:

PCI did not effectively lobby for Pharm.D graduates to be recognized as Clinical Pharmacists or Pharmacotherapy Specialists under national health schemes or in state public health systems. Consequently, there are limited government posts specifically designed for Pharm.D graduates.

4. Lack of Outcome-Based Evaluation:

PCI has not periodically assessed the program outcomes in terms of employment, career progression, or role recognition of Pharm.D graduates. This has allowed gaps to widen between academic training and real-world practice.

5. Overexpansion Without Planning:

Many colleges were allowed to start Pharm.D programs without adequate hospital tie-ups or infrastructure, leading to variable quality of training and overproduction of graduates without matching demand in the healthcare sector.

6. No Defined Scope of Practice:

PCI has not succeeded in securing a legal and professional scope of practice for Pharm.D graduates that is distinct from other pharmacy qualifications, leading to confusion and underutilization of their clinical skills.

While PCI’s intention was commendable, its execution lacked foresight, planning, and collaboration. 

The responsibility now lies with PCI to rectify this through policy advocacy, defining roles for Pharm.D graduates, ensuring integration with national health systems, and creating a viable career pathway to prevent further professional disillusionment and brain drain.

Government of India should intervene, dismiss the Deadwood's and appoint an administrator of IAS  cadre to save the Profession in public interest.

#PMO, #HFW

Pov: Bhagwan P. S

Pharmacy - beyond the counter - Patient centric.

Pharmacy - beyond the counter - Patient centric.

Pharmacy, once seen as a profession behind the counter or within the factory walls, is today poised for a transformation. 

The pharmacist is evolving into a critical member of the healthcare team, contributing to patient care, therapy optimization, public health, and even disaster management. 

Yet, despite this exciting evolution, our pharmacy colleges are struggling to match pace. The ailments are deep-rooted, but curable—with vision, reform, and a renewed commitment to quality.

At the heart of the issue lies the quality of student admissions. For many, pharmacy is not a first-choice profession. It is often a fallback, filled through vacant seats rather than merit-based enthusiasm. This has diluted the academic ecosystem, resulting in a large number of graduates who lack the passion or preparedness for a demanding healthcare role. 

Equally urgent is the need for high-caliber faculty. A great teacher can ignite a lifelong spark, but many colleges lack such mentors.

 Faculty development programs have to be more effective and impact ful,  salaries are uncompetitive, and industry or clinical exposure is minimal. Institutions must invest on faculty, their training, research engagement, and continuous professional development, aligning educators with global standards. Strong mentors alone can produce , strong professionals.

The absence of a central body like a National Pharmacy Council (NPC) to replace weak fragile PCI to standardize education, licensure, and practice scope adds to the vows of the colleges and education in general.  

An empowered NPC can uplift the profession by enforcing quality norms in admissions, curriculum design, institutional infrastructure, faculty competency, and student assessment—just as the NMC does for medicine or INC for nursing.

Exposure of Students graduate with  to real-world challenges. Internships, interdisciplinary learning, clinical postings, and innovation labs should be made compulsory and meaningful.

When the Pharmacists come out with inbuilt professional quality the demand for their service increases.

The time to heal is now—and with the right reforms, pharmacy education can not only recover but qualitatively support healthcare service.

Pov: Bhagwan P. S

POV :

Earlier there was MCI equivalent to PCI.

Then MCI got changed to NMC.

Now he is talking about bringing up NPC equivalent to NMC. 

What a mess? 

PCI & MCI now NMC.

Whats the job of the Representative from MCI now NMC in PCI?

Do we have PCI Representative in MCI now NMC?

Indian Health System practices untouchability towards Pharma Professionals!

Looks PCI failed to gel and coordinate with MCI now NMC in professional matters.

When PCI doesn't gel, how can the Pharmacists gel with Healthcare professionally.

This appears to be the root cause for B, M Pharm and Pharm Ds being stranded with no opportunity to serve in Healthcare.

Please correct me if I am wrong.

Please narrate your experience, observation, views in the comment box.

Reactions like 👍 mean nothing.

POV: Bhagwan P. S

#PharmacyCouncilOfIndia – A Body with wasted muscle! 😢

#PharmacyCouncilOfIndia – A Body with wasted muscle! 😢

PCI governs but fails to enforce!

The Pharmacy Council of India (PCI), established under the Pharmacy Act, 1948, was meant to uphold the standards of pharmacy education and practice in India. 

But over the decades, while pharmacy evolved globally into a clinical and patient-centric profession, PCI has largely remained a regulator with outdated tools, limited vision and action short of reach.

At the heart of the problem is the Pharmacy Act itself — a law that has not kept pace with modern healthcare demands. It offers regulatory control but not reformative power. There is no legal push for advanced clinical training, integration into hospital systems, or patient care competencies. PCI continues to regulate based on a mid-20th-century model while the 21st-century healthcare system demands innovation.

Equally concerning is the composition of PCI’s council. Though it includes representatives from states, universities, and other bodies, the quality and commitment of members vary widely. Many are driven by institutional or political loyalties and it is a decoration for majority rather than professional advancement. As a result, council meetings become administrative rituals to clear 100+agenda, not platforms for national vision.

The approval and inspection process — central to PCI’s role — is also deeply flawed. Inspections often focus on paperwork over substance. Colleges with poor infrastructure, unqualified faculty, and negligible hospital exposure continue to get approvals.

 Allegations of bias and irregularities have further eroded trust in the system.

Meanwhile, thousands of pharmacy graduates face unemployment or underutilization due to diluted quality, no direction, outdate Curricula . Clinical exposure is minimal, in total degree without skill

PCI has not done enough to push for curriculum reform, standardized hospital training, or alignment with national health priorities.

Instead of being a think-tank and  thought leader, PCI often functions as a passive regulator. 

It has failed to advocate strongly for pharmacy graduates roles in public health, disaster preparedness, or clinical care. It has missed collaborating opportunities with AICTE, NMC, and global pharmacy bodies. Even in times of health crises, the pharmacist’s potential role remains un-recognized  underutilized — PCI has done little to break.

Above all, PCI lacks a National vision and Professional mission. It governs but does not lead. It regulates but does not inspire.

If pharmacy is to rise as a pillar of India’s healthcare system, PCI must transform — from a bureaucratic mode to a reformist force. This means amending the Act, raising the quality of its members, enforcing outcome-based education, and embedding pharmacy into the core of public health systems.

Until then, the profession will remain full of potential on paper and PCI, a symbol of how not to use it.!!!

Hope the message is  clear.. 👍

Lets debate...

Pov: Bhagwan P. s

Clinical Subjects like Pathophysiology and Clinical Pharmacokinetics require qualified faculty like M. D Pharmacologists for teaching in these universities and colleges with Pharm D and Pharm D (PB) courses in its initial stages.

Clinical Subjects like Pathophysiology and Clinical Pharmacokinetics require qualified faculty like M. D Pharmacologists for teaching in these universities and colleges with Pharm D and Pharm D (PB) courses in its initial stages.

Mohalla Clinic , Mohalla Pharmacy

A Mohalla Clinic is a primary health center in India that offers free essential health services to the community: 

• Services: Free consultations, diagnostics, and medicines
• Location: Located within a kilometer of the patient's home 
• Purpose: To reduce the financial burden on low-income households by providing free healthcare and saving travel costs 
• Name: The word mohalla in Hindi means "neighborhood" or "community"

How about a Mohalla Pharmacy? 

A different POV : Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector

A different POV : Pharmacists have failed to impress professionally and leave professional footprints in Healthcare Sector . Therefore requirement of a new course like Pharm D / Pharma D (PB), which will produce professionals called Pharmacist and Pharmacotherapist. 

Is it true ? Really!!! 

Projects types in higher education

Either a project work requiring technology use like smart mobile camera , scanner, computer etc. 

Or a project work without much of technology use. Only manual operated. 

Leveraging DigiPharmed for Pharmacy Education and Practice

A Proposal to the Pharmacy Council of India (PCI): 

Leveraging DigiPharmed for Pharmacy Education and Practice

To: The Pharmacy Council of India (PCI)

Subject: Adoption of Digital Technologies under the Concept of "DigiPharmed"

Respected Members of the Pharmacy Council of India,

With the rapid evolution of digital healthcare globally, the integration of digital technologies into pharmacy education and practice is crucial. The concept of DigiPharmed—the use of digital innovations in pharmacy—offers a pathway to transform pharmacy services and elevate the role of pharmacists in India's healthcare system.

Below are the proposed suggestions for PCI to adopt and implement DigiPharmed initiatives:

1. #integrationOfDigitalHealth - IntoPharmacy Education

Incorporate health informatics and digital health technologies into the pharmacy curriculum (e.g., AI, machine learning, blockchain, telepharmacy, and digital therapeutics).

1. #DevelopVirtualLabsAndSimulation - Based training platforms for practical skill enhancement.

Introduce specialized certifications in areas like telepharmacy operations, pharmacovigilance through digital platforms, and digital therapeutics.

2. Promotion of Telepharmacy and Remote Healthcare Services

a. Establish guidelines for ethical telepharmacy practices, ensuring compliance with national laws like the Drugs and Cosmetics Act.

b. Create a framework for training pharmacists in teleconsultation, remote medication management, and e-prescriptions.

c. Collaborate with state health departments to implement telepharmacy services in rural and underserved areas.

3.#AlignmentWithNationalDigitalHealthMission (NDHM)

a. Actively participate in the Ayushman Bharat Digital Mission (ABDM) by:

b. Integrating pharmacists into electronic health record (EHR) systems.

c. Training pharmacy professionals to use digital prescription platforms and healthcare interoperability tools.

4.#DigitalEnabledPharmacovigilance

a. Promote the use of digital tools like the PvPI (Pharmacovigilance Programme of India) mobile app for real-time adverse drug reaction reporting.

b. Encourage automation in pharmacovigilance systems to ensure safety and efficiency

5. #CapacityBuilding - Under Continuous Education

a. Conduct national-level workshops and webinars to train pharmacists in digital healthcare tools and emerging technologies.

b.  Collaborate with technology partners to provide access to the latest innovations in pharmacy practice.

6. #AddressThe Challenges - in Creating Opportunities

a. Position pharmacists as key contributors in India’s digital healthcare transformation.

b. Facilitate partnerships with global and national tech companies to introduce cutting-edge solutions in pharmacy practice.

At the outset,  By adopting the concept of #DigiPharmed and #PharmacarePCI can revolutionize pharmacy education and practice, enhancing accessibility, efficiency, and healthcare outcomes across India. This initiative will also position India as a global leader in digital pharmacy innovations.

I urge PCI to consider these suggestions and take a proactive role in implementing DigiPharmed strategies for the future of pharmacy profession in India.

With sincere regards,

Bhagavan P. S.

Retd. Dy Dir. Pharmacy

H&FWS, Karnstaka.

Frmr. Registrar, KSPC

Bengaluru.

#PCI

#APTI

Someone kindled me to define and explain who is Healthcare professional? Where does the Pharmacist fit in?

Healthcare Professional.

Someone kindled me to define and explain who is Healthcare professional? Where does the Pharmacist fit in?

Not an easy question in light of Second question.

Any professional who serves the humans to safeguard his / her health and serves to mitigate the suffering and assists and supports the patient to be as comfortable as possible and treats him directly and fecilitates treatment could be called healthcare professional or Health Worker. All put together could be called a Medical Team

[This is my own extempore definition, I am subject to correction]

Now coming to second question,

Where does the Pharmacist fit in to be called Healthcare professional?

Excluding Pharm D Pharmacists, considering prevailing scenario and practice in India  the Pharmacist looks like a supporter external to the Treatment team  only to dispense what is advised. 

Unless the Pharmacists update themselves  or Course content is updated to familiarise the students on healthcare practices in preventive and curative services Pharmacists of India may not gain the Healthcare Professional tag.

#PCI, #IPA, #APTI,

POV :Bhagwan PS

Sch K amendment - Has these Objectives been Achieved?

Sch K amendment - Has these Objectives been Achieved?

The amendments to Schedule K of the Drugs and Cosmetics Rules, 1945, introduced significant changes to streamline drug regulations and accessibility. Here’s a comparative summary of the situation before and after the amendment:

👉Before the Amendment

1. Applicability and Scope:

Schedule K exempted certain classes of drugs and circumstances from specific provisions of the Drugs and Cosmetics Act, such as licensing requirements.

Focused primarily on traditional practices like home remedies, medicines for medical professionals' personal use, and drugs distributed under government programs.

2. Community Pharmacist Role:

Limited emphasis on the active role of community pharmacists in drug dispensing.

Drugs like antimalarials, contraceptives, and certain public health program-related medications were exempt from licensing under specific distribution schemes.

3. Challenges:

Regulatory gaps led to potential misuse and lack of uniformity in drug dispensing.

Limited coverage for modern healthcare needs.

The evolving role of pharmacists was not well-integrated.

👉After the Amendment

1. Expanded Scope and Clarity:

The amended Schedule K included clearer definitions and expanded exemptions to include new healthcare settings, such as telemedicine, e-pharmacies, or alternative delivery mechanisms.

Streamlined processes for government health programs.

2. Enhanced Role of Pharmacists:

Stronger emphasis on the role of qualified pharmacists in dispensing drugs exempted under Schedule K.

More robust inclusion of community pharmacists to bridge healthcare access gaps.

3. Strengthened Public Health Initiatives:

👉Better alignment with national health priorities, including immunization, TB control, and other public health programs.

Rationalized exemptions for drugs used in specific national healthcare programs, reducing regulatory delays.

4. Digital and Telemedicine Integration:

Eased rules for modern dispensing methods, recognizing the role of digital healthcare and online pharmacies in delivering medicines, especially in remote areas.

5. Regulatory Compliance:

👉Tighter monitoring of exempted drug categories to reduce misuse or diversion.

Improved documentation and accountability measures.

👉Impact of the Amendment

Improved Accessibility: Rural and underserved regions benefited from greater accessibility to essential medicines without unnecessary bureaucratic hurdles.

Pharmacist Empowerment: Elevated pharmacists’ status as critical stakeholders in ensuring safe drug delivery and patient counseling.

Adaptation to Modern Healthcare Needs: Regulatory provisions evolved to accommodate digital healthcare platforms, telemedicine, and innovations in drug distribution.

These changes have harmonized regulations with the dynamic healthcare landscape while ensuring public safety and enhancing pharmacists' contributions to patient care.

Has this not made 'Pharmacist' dispensable/Replaceable and Substitutable?

PCI has a right to verify and demand reversal if it is found curtailing the scope of the profession and professionals

POV : Bhagwan PS

The "Schedule K of the D&C Act," 1948, which allows the Indian Doctor to dispense ,Sell Medicine without any Drug Licence .... Which is a Criminal offence in All the countries of the world... In older times when there were not enough Pharmacy/ Chemist shop, and the shops closed at 8 pm... the Doctors and Clinics who needed Medicine in case of emergencies were allowed to keep emergency medicine for patients, and a amendment was made in the D&C act... Called the Schedule k... Which allows the Indian Doctor to keep Medicine at his clinic/ nursing home... without any Drug Licence... But now with availability of 24 hrs Pharmacy/ Chemist shop... This rule should have been abolished as elsewhere in rest of the world... Where a Doctor cannot keep/ sell even a paracetamol from his Clinic/ nursing home.... But in India, since the Pharma lobby is controlled by the IMA... This law has not been changed... And this is the reason which even a Quack can be allowed to keep Medicine in his clinic and dispensing and loose Medicine are allowed in India... The IMA is to blame for mushrooming of the Quacks and even the misuse of Schedule k, of the D&C Act, 1948 by The Nursing Homes, Clinic and Hospital ...  Leaving the pharmacist to just use the "Pharmacist License" to Open a Chemist/ Pharmacy shop ....A Pharmacist who is an expert in Medicine/ Drug in India , is left just with a work to pass on the Medicine to the patient as a salesman... While in rest of the world, a Patient looks forward to getting expert advice by a Clinical Pharmacist on the correct dosage and per kg body wt. Calculated exact dosage schedule ( in case of Critical medicines),  precautions, monitoring and reporting any side effects, adverse effects of a Drug prescribed by a Doctor. Across the world, No person except the Pharmacist can dispense, sell or guide anyone on the Medicine/ Drug.

GSR 220 cancellation request

कोरोना काल में दवा बिक्री को लेकर जारी अधिसूचना को रद्द करे सरकार

भागलपुर केमिस्ट एंड ड्रगिस्ट एसोसिएशन के महासचिव प्रशांत लाल ठाकुर ने कोरोना संक्रमण को रोकने के लिए जारी अधिसूचना जीएसआर 220 (ई) को रद्द करने की मांग की है। उनका कहना है कि डिजिटल प्लेटफार्म बिना वैध..

भागलपुर, वरीय संवाददाता कोरोना संक्रमण को रोकने के लिए दवा बिक्री को लेकर जारी अधिसूचना जीएसआर 220 (ई) को भागलपुर केमिस्ट एंड ड्रगिस्ट एसोसिएशन के महासचिव प्रशांत लाल ठाकुर ने रद्द किए जाने की मांग की है। उन्होंने कहा कि ये अधिसूचना कोरोना काल में स्थानीय दवा विक्रेताओं को इमरजेंसी के आधार पर स्थानीय दवा दुकानदारों को घर-घर दवा पहुंचाने की सुविधा देने के लिहाज से जारी की गई थी। लेकिन मौजूदा काल में कई डिजिटल प्लेटफार्म इस अधिसूचना का दुरुपयोग कर बिना किसी वैध प्रिस्क्रिप्शन के घर-घर दवाई पहुंचा रहे हैं। जो रोगाणुरोधी प्रतिरोध, नशीली दवाओं के दुरुपयोग और स्वचिकित्सा जैसी समस्याओं को जन्म दे सकती है। ऑनलाइन दवा बेच रहे प्लेटफार्म का ध्यान केवल उनके अपने मुनाफे पर है। यदि इस अधिसूचना पर रोक नहीं लगती है तो ये ऑनलाइन कारोबार जनता की सेहत के लिए खतरे का सबब बन सकता है। ऐसे में इस अधिसूचना को रद्द कर दवाओं की बिक्री और वितरण के लिए प्रिस्क्रिप्शन और अन्य नियामक प्रावधानों का कड़ाई से पालन कराया जाय. 

Protect your Pharmacist

Physicians are well protected by their own folks.

They are 'No Wrong Doers'!

Who should protect the Pharmacists in the service and in the Regulatory?

#RegulatoryOfficersAssociation

#IPA

#IHPA

#APTI

#AIOCD

#PharmacistsAssociation

Reality against Myths (PCI book)😢What PCI has to say?

Reality against Myths (PCI book)😢

What PCI has to say? 

Drugs Control officers can not take action for non compliance with  PPR or Pharmacy Act. 

Incidentally, the term " Pharmacy" contemplated under Rule 65(15)(c) refers to establishments complying with Schedule N of Drugs and Cosmetics Rules. For records, establishments possessing license for " Pharmacy" in compliance with Schedule N is in single digits, may be TWO or THREE in the entire State of Karnataka. Even these two or three need not comply with PPR. They have to comply with Schedule N.

Let me also clarify that the medical shops where D.Pharm holders are engaged and whose number in the State is more than 30000 and for whose upliftment you are fighting for are referred as " Chemists and Druggists " under Rule 65(15)(c).

 

I have been saying PPR has no legal sanctity. None has bothered to look into this and everyone harps on implementing PPR.  

Lastly, :

1. To implement SECTION 42 of Pharmacy Act separate authority is contemplated. State Councils are accountable if they have not appointed inspectors to implement Section 42 for decades.

2. Your observation Drugs regulatory together with State pharmacy Council can make the system water tight for violators is a wishful thinking."...

Unquote:

... 😢

Attn:#PCI

This has happend is happening because:

1.PCI administrators do not know how to administer the office.

2. PCI do not follow Government Office Manual and PCI is being managed without due documentation and #Accountability, otherwise how the President's resignation letter was accepted without scrutiny and someone takes over without any fuss.

4.PCI is playing irresponsibly with the life of millions of youngsters leaving them Blindfold!

5. PCI is  luxurious jambooree to the members to make family trips.

Poor pharmacists 😢

POV : Bhagwan PS